Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 19.8B | 21.9B | 21.7B | 20.5B |
Cost of revenue | 9.7B | 10.4B | 10.4B | 10.3B |
Gross profit | 10.1B | 11.5B | 11.3B | 10.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 5.5B | 5.7B | 5.5B | 6.3B |
Other operating expenses | — | — | — | — |
Operating income | 4.6B | 5.7B | 5.8B | 3.9B |
Non operating interest income | ||||
Income | 111M | 119M | 135M | 107M |
Expense | 217M | 240M | 238M | 220M |
Other income expense | 210M | 224M | -554M | 98M |
Pretax income | 4.7B | 5.8B | 5.1B | 3.9B |
Tax provision | 868M | 1.2B | 1.2B | 726M |
Net income | 3.8B | 4.7B | 4.0B | 3.1B |
Basic EPS | 1.6 | 1.9 | 1.7 | 1.3 |
Diluted EPS | 1.5 | 1.9 | 1.6 | 1.3 |
Basic average shares | 2.3B | 2.4B | 2.4B | 2.4B |
Diluted average shares | 2.4B | 2.5B | 2.5B | 2.5B |
EBITDA | 5.6B | 6.8B | 6.1B | 4.9B |
Net income from continuing op. | 3.8B | 4.7B | 4.0B | 3.1B |
Minority interests | -23M | -29M | -28M | -7M |
Preferred stock dividends | — | — | — | — |